Verde Bio Holdings, Inc. income statement APHD

It recorded a net loss of $1.9 million. Across the 6 fiscal years shown, revenue grew from $1,544 in fiscal 2012 to $41,850 in fiscal 2018, about 93.5% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2021
Jan 31, 2021
FY 2023
Apr 30, 2023
FY 2022
Apr 30, 2022
FY 2018
Apr 30, 2018
FY 2017
Apr 30, 2017
FY 2015
Apr 30, 2015
FY 2014
Apr 30, 2014
FY 2013
Apr 30, 2013
FY 2012
Apr 30, 2012
Revenue
—
—
—
0
-16.8%
0
+1746.0%
0
-46.8%
0
-29.6%
0
-55.4%
0
Cost of revenue
—
—
—
0
+5.4%
0
—
—
—
—
Gross profit
—
—
—
0
-34.3%
0
—
—
—
—
Selling, general and administrative
—
—
—
0
+11.9%
0
+370.3%
0
+2872.5%
-0
-115.2%
0
-42.9%
0
Operating income
-1
-365.0%
-2
+47.9%
-3
-6.2%
-0
+1.2%
-0
-132.4%
-0
-73.6%
-0
+16.4%
-0
—
Other income (expense)
-0
+67.7%
-0
+50.6%
-0
+22.0%
-1
+37.3%
-2
-2458.4%
-1
-108.8%
-0
—
—
Pretax income
—
-2
+48.2%
-3
-3.2%
-1
+29.6%
-2
-1589.6%
-1
-97.1%
-0
-182.0%
-0
+1.4%
-0
Income tax
—
0
0
0
0
0
—
—
—
Net income
—
-2
+45.9%
-3
-1
+29.6%
-2
-1
-97.1%
-0
-235.0%
-0
+16.9%
-0
Other measures
Depreciation and amortization
—
0
—
—
—
0
—
0
-12.0%
0
EBITDA
—
-2
—
—
—
-0
—
-0
—
Interest coverage
-1.91x
-24.89x
—
-1.51x
-2.51x
-1.75x
-34.02x
-435.88x
—
Margins
Gross margin
—
—
—
44.27%
56.04%
—
—
—
—
Operating margin
—
—
—
-1,077.18%
-906.74%
-90,510.08%
-27,729.69%
-23,343.83%
—
Pretax margin
—
—
—
-3,572.29%
-4,219.86%
-309,250.00%
-83,464.33%
-20,830.91%
-9,423.12%
Profit margin
—
—
—
-3,572.29%
-4,219.86%
-309,250.00%
-83,464.33%
-17,538.32%
-9,423.12%
EBITDA margin
—
—
—
—
—
-90,412.40%
—
-23,267.05%
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Crude Petroleum & Natural Gas (SIC 1311)
Listed as
APHD (OTC)
Fiscal year ends
April 30
Incorporated in
NV
Headquarters
Frisco, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1490054
Former names
APPIPHANY TECHNOLOGIES HOLDINGS CORP (until Aug 20, 2020)

Other Crude Petroleum & Natural Gas companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.